At a glance

ClinicalIndex Comparison Record

Phase 3Completed

Drug / intervention

imipramine +6 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000518

NCT00000518Phase 3Completed

Compare CT.gov

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)

University of Utah·interventional·Posted Oct 28, 1999·Updated Jan 21, 2016

In Brief

A Phase 3 clinical trial evaluating electrophysiology, electrocardiography, ambulatory, and 5 other interventions for Arrhythmia and 6 related conditions. Completed.

Detailed Summary

To determine whether electrophysiologic study (EPS) or Holter monitoring (HM) was the better method for selecting effective long-term antiarrhythmic drug therapy in patients with sustained ventricular tachycardia, ventricular fibrillation, or an episode of aborted sudden death.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsArrhythmia, Cardiovascular Diseases, Death, Sudden, Cardiac, Heart Diseases, Tachycardia, Ventricular, Ventricular Arrhythmia, Ventricular Fibrillation

Countries--

CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished

1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartJul 1985

Study CompletionDec 1992

First PostedOct 1999

TodayJul 2026

First PostedOct 28, 1999

Enrollment StartJul 1, 1985

Study CompletionDec 1, 1992

TodayJul 2, 2026

Posted 26.7 years ago

Interventions

electrophysiologyprocedure

electrocardiography, ambulatoryprocedure

imipraminedrug

mexiletinedrug

procainamidedrug

quinidinedrug

sotaloldrug